NCT02117206View on ClinicalTrials.gov

Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2012

Study Completion Date

November 30, 2013

Conditions
Skeletal Muscle IschemiaSevere Lower Limb IschemiaMitochondrial Dysfunction
Interventions
DRUG

L-arginine (L-arginine Veyron)

DRUG

Nacl

Trial Locations (1)

67091

SERVICE DE PHYSIOLOGIE ET D'EXPLORATIONS FONCTIONNELLES- Nouvel Hôpital Civil, HUS, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT02117206 - Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans | Biotech Hunter | Biotech Hunter